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the study, indicating that the treatment protocol is
applicable for most clinical situations.
The biological rationale for including rifampi-
cin in the treatment of prosthetic device infec-
tions has been reviewed previously [10–12]. Its
excellent bioavailability with oral intake reduces
the need to remain in hospital, and helps mini-
mise the complications and costs associated with
long-term intravenous therapy. The main role of
an accompanying antibiotic is to protect against
the development of rifampicin resistance, which
occurs readily as a result of a single point
mutation. Ciproﬂoxacin is a rational choice, given
its good activity against Staphylococcus aureus,
excellent oral absorption, and activity against
adherent bacteria [13]. However, the use of
rifampicin on a routine basis for all orthopaedic
prosthetic joint infections should be discouraged.
Rifampicin is a valuable antibiotic, but has been
shown to be effective only in early-onset
infections; late-onset infections cannot usually
be eradicated without prosthesis removal [6].
In conclusion, low failure rates were achieved
following early manifestation orthopaedic pros-
thetic joint infections, without prosthesis removal,
when thorough debridement was followed by
treatment for 3 months with oral rifampicin and
ciproﬂoxacin. The success rates obtained were
comparable to those achieved in the only pub-
lished randomised controlled trial concerning
these infections. The proposed strategy for man-
agement of early manifestation implant infections
seems, therefore, to be an effective and safe option.
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ABSTRACT
During a 6-year observational study, 122 cases of
hepatitis A virus (HAV) infection were detected
in Bologna, Italy, with a c. 300% increase in cases
between 1999 and 2004. There were 104 cases
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(85.2%) in male adults, of whom nearly 70% had
unprotected sexual contact as the probable risk-
factor. There were increasing numbers of cases in
immigrants between 1999 and 2004 (p 0.036), and
concurrent cases of infection with human immu-
nodeﬁciency virus, hepatitis B and C viruses and
syphilis were also noted in adult males (p 0.0032).
There is a need to re-emphasise targeted educa-
tional programmes and anti-HAV vaccination for
at-risk subjects.
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Hepatitis A virus (HAV) is transmitted through
oral–faecal contact. The illness is usually charac-
terised by a self-limiting inﬂuenza-like syndrome,
later accompanied by jaundice, but complications
may occur at an appreciable frequency in immu-
nocompromised or co-infected subjects [1–3].
Outbreaks of HAV infection have been observed
worldwide, particularly in homo ⁄bisexual men
[4–7], but also in injecting drug users and home-
less individuals [3], who may be exposed to
parenteral–sexual infections. The present report
describes an observational survey of all hospital-
isations associated with acute HAV infection (122
patients) that occurred in the Bologna metropol-
itan area (population c. 500 000) between 1 Janu-
ary 1999 and 30 April 2004. Serological diagnosis
of HAV was performed with the AxSYM HAV-
AB-M 2.0 assay (Abbott, Abbott Park, IL, USA).
All cases of HAV infection were also investigated
with regard to demographic, epidemiological and
clinical parameters.
Since October 2002, HAV has been the most
frequently recognised cause of acute hepatitis
among inpatients in this region. Although there
was a slight seasonal variation (57.4% of 122 cases
notiﬁed in April–September, compared with
24.6% in October–March), analysis of other var-
iables supported a change in the epidemiology of
the disease, despite the introduction of anti-HAV
vaccination in 1995, and the recommended use of
barrier prophylactic methods since the beginning
of the human immunodeﬁciency virus (HIV)
pandemic in the early 1980s.
Only 18 (14.8%) patients were adult females or
children (aged 4–9 years), with a temporal trend of
diagnosis which remained essentially unchanged.
The number of cases among immigrants increased
from 1–3 cases ⁄ year in 1999–2001 to 12 cases ⁄ year
between January 2003 and April 2004 (p 0.036).
Two pairs of immigrant siblings (aged 6–8 years)
were hospitalised with HAV infection in 2003.
Most (n = 104; 85.2%) HAV patients were males
aged 22–44 years (mean 28.3 ± 4.3 years). When
possible risk-factors for HAV in this group were
examined, only 14 (13.5%) patients reported
consumption of potentially contaminated raw
food, shellﬁsh or water, or recent trips to endemic
countries. In contrast, 81 (77.9%) reported unpro-
tected homo ⁄ bisexual contact in the 2 months
preceding the onset of HAV infection. In the
remaining nine (8.6%) cases, epidemiological data
were incomplete. Among the 16 immigrants, 14
were adult males (11 having had homosexual
contact and three cases with incomplete informa-
tion). There were no reported contacts with
recently diagnosed HAV patients, and none of
the cases had received anti-HAV vaccination.
Among the 104 adult males, concurrent infec-
tionswere found in 34 cases (p 0.0032), comprising
infections with chronic hepatitis B virus (HBV)
(n = 6), hepatitis C virus (n = 12), syphilis (n = 5),
and HIV (n = 11) (with one case of HBV and two
cases of HIV infection disclosed concurrently with
HAV). One patient with HAV–HIV co-infection,
and a CD4+ lymphocyte count of 232 cells ⁄lL, had
a prolonged and relapsing course of HAV infec-
tion, with normalisation of liver abnormalities
being reached only after 4 months. A further three
patients had a prolonged relapsing course of
HAV infection, with late (11–16 weeks) but stable
normalisation of serum transaminases. The num-
ber of male adults admitted for HAV infection
showed a signiﬁcant increase over the study
period, with 14 cases diagnosed in 1999, 13 in
2000, 18 in 2001, 23 in 2002, and 38 in 2003 (a c. 300%
increase compared to 1999, leading to a crude
estimate of 7.6 cases ⁄ 100 000 residents ⁄year), and
12 new episodes in the ﬁrst 111 days of 2004
(p < 0.0001 vs. 1999; Fig. 1).
HAV infection is usually mild, but there is a
higher fatality rate in the young and old, and
when concurrent chronic liver disease or concom-
itant immunodeﬁciency are present [1–3].
Although food- or water-borne transmission of
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HAV still occurs in endemic [8] and non-endemic
areas [9], and outbreaks may also occur from
unlikely food sources, such as raw blueberries
[10], syringes shared by drug users are an import-
ant source of outbreaks of HAV [3,5]. Despite the
availability of a vaccine and information cam-
paigns directed against the spread of sexually
transmitted diseases and HIV, the increased pre-
valence of homo ⁄ bisexual transmission over other
oral–faecal routes has led to the rapid and contin-
ued spread of HAV. Although an Italian serolog-
ical survey in Rome in 1999 seemed to exclude an
increased risk of HAV infection among homosex-
uals [11], increased evidence for homo ⁄ bisexual
HAV transmission has been reported from The
Netherlands [4], the UK [6], Australia [5], Japan [2]
and Norway [7]. A telephone survey in 1996
among New Zealand men who have sex with men
disclosed a 7% incidence of HAV infection among
1852 respondents, with HAV infection being
associated with older age, number of lifetime
partners, visits to sex venues, and an HIV-positive
serostatus [12]. A seroprevalence study among 833
homo ⁄ bisexual males aged 15–29 years in the
USA detected HAV infection in 13.9% of subjects,
with at least 57.9% of these 833 individuals
remaining susceptible to HAV, and most being
unaware of the availability of a vaccine [13].
The present study, although limited by the
number of patients, period and area of observa-
tion, demonstrated a link between new cases of
acute HAV infection and homo ⁄ bisexual activity.
An association between prolonged HAV disease
and HIV infection (as observed for one patient in
the present study) has been described in fewer
than ten patients [1,2], although Ida et al. [2]
described an unexpectedly long period of HAV
viraemia among 15 males co-infected with HIV
and HAV. Careful epidemiological monitoring,
coupled with speciﬁcally targeted educational
campaigns and public health measures (e.g., im-
munoprophylaxis for patients with at-risk beha-
viour), should help to contain the rising incidence
of HAV infection among homo ⁄ bisexual men in
northern Italy, and concurrently reduce the spread
of other sexually transmitted pathogens such as
HBV, hepatitis C virus, HIV and syphilis. An
increased awareness of risks associated with oral–
faecal contamination should result in improved
hygiene measures [4,5], eventual post-exposure
prophylaxis with anti-HAV immunoglobulins [9],
and extensive anti-HAV vaccination campaigns
for (or possible co-administration of HAV–HBV
vaccines to) at-risk individuals [2,3,5,6,13–15].
Homo ⁄bisexual men usually belong to self-moti-
vated andwell-informedcommunities,whichhave
a high understanding and acceptance of prophy-
lactic measures. Such public health measures
should also help to prevent the spread of sexually
transmitted diseases and foodborne infections
among the general population.
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Fig. 1. Cases of hepatitis A diagnosed in the Bologna
metropolitan area, Italy since 1999, according to the year of
diagnosis. Male adult patients (with a 70% prevalence of
ascertained homo ⁄bisexual behaviour) are compared with
all patients hospitalised as a result of hepatitis A virus
infection.
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ABSTRACT
The Directigen Flu A+B enzyme immunoassay
and the Abbott TestPack RSV enzyme immuno-
assay were each compared with a multiplex
RT-PCR ELISA by testing 635 nasopharyngeal
aspirates collected from children aged < 16 years
who had been hospitalised with acute respiratory
tract infection during the epidemic season
2002–2003. In this study, the sensitivity of the
Directigen Flu A+B assay was unacceptably low
(29.3% and 10.0%, respectively) for the detection
of inﬂuenza A and B viruses. The sensitivity of the
Abbott TestPack RSV assay (77.4%) was accep-
table and in agreement with the multiplex
RT-PCR ELISA.
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Inﬂuenza virus and respiratory syncytial virus
(RSV) are the most common of the highly conta-
gious respiratory pathogens, and are responsible
annually for considerable morbidity and mortality
[1]. Rapid diagnosis of respiratory tract infection is
important for focused and timely therapeutic
intervention, for hygiene measures and for iden-
tiﬁcation of outbreaks [2]. Anti-inﬂuenza virus
medications are most effective when they are
given within 48 h of the onset of symptoms [3].
The present study evaluated the Directigen Flu
A+B enzyme immunoassay (EIA) (Becton Dickin-
son, Heidelberg, Germany) for the detection and
differentiation of inﬂuenza A and B viruses, and
the Abbott TestPack RSV EIA (Abbott Laborator-
ies,Wiesbaden, Germany) for the detection of RSV.
These two assayswere comparedwithin a network
for acute respiratory tract infection in children
(PID-ARI.net,http://www.pid-ari.net)withamul-
tiplex (m)-RT-PCR ELISA which detects 19 patho-
gens, including inﬂuenzaAvirus, inﬂuenzaBvirus
and RSV. The latter test is an advanced m-RT-PCR
ELISA based on a validated m-RT-PCR ELISA
method [4] for the detection of nine pathogens [5].
In a prospective study, 635 specimens were
collected during the epidemic season 2002–2003.
Specimens were exclusively nasopharyngeal
aspirates from patients aged 0–16 years (median
2.25 years) admitted to the Department of Paedi-
atrics, Johannes Gutenberg University, Mainz,
with acute community-acquired lower respiratory
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